Cargando…

New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence

Nowadays, cardiac regeneration is an emerging topic in the cardiovascular field because of the compelling need for effective therapies for repairing or replacing cardiac tissue damaged by pathological or physiological conditions. Indeed, irreversible myocardial remodeling which follows acute myocard...

Descripción completa

Detalles Bibliográficos
Autores principales: Rurali, Erica, Vinci, Maria Cristina, Bassetti, Beatrice, Barbagallo, Veronica, Pompilio, Giulio, Gambini, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493790/
https://www.ncbi.nlm.nih.gov/pubmed/32096748
http://dx.doi.org/10.2174/1574888X15666200225124451
_version_ 1784579188890533888
author Rurali, Erica
Vinci, Maria Cristina
Bassetti, Beatrice
Barbagallo, Veronica
Pompilio, Giulio
Gambini, Elisa
author_facet Rurali, Erica
Vinci, Maria Cristina
Bassetti, Beatrice
Barbagallo, Veronica
Pompilio, Giulio
Gambini, Elisa
author_sort Rurali, Erica
collection PubMed
description Nowadays, cardiac regeneration is an emerging topic in the cardiovascular field because of the compelling need for effective therapies for repairing or replacing cardiac tissue damaged by pathological or physiological conditions. Indeed, irreversible myocardial remodeling which follows acute myocardial infarction represents a serious burden of this century. In this context, a great improvement in pharmacological and interventional techniques is accompanied by a big challenge of cardiac regenerative medicine. In the last 20 years, several clinical trials tried to investigate the role of different types of stem cells in promoting cardiac repair. However, the promising results obtained in the preclinical trials have not yet been reproduced in patients. Thus, the development of novel strategies to improve stem cell efficiency became imperative. Here, an overview of the more recent cell types proposed for cardiac regeneration is presented, together with the most interesting approaches to enhance cell regenerative potential as well as cell-free approaches.
format Online
Article
Text
id pubmed-8493790
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-84937902021-11-02 New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence Rurali, Erica Vinci, Maria Cristina Bassetti, Beatrice Barbagallo, Veronica Pompilio, Giulio Gambini, Elisa Curr Stem Cell Res Ther Article Nowadays, cardiac regeneration is an emerging topic in the cardiovascular field because of the compelling need for effective therapies for repairing or replacing cardiac tissue damaged by pathological or physiological conditions. Indeed, irreversible myocardial remodeling which follows acute myocardial infarction represents a serious burden of this century. In this context, a great improvement in pharmacological and interventional techniques is accompanied by a big challenge of cardiac regenerative medicine. In the last 20 years, several clinical trials tried to investigate the role of different types of stem cells in promoting cardiac repair. However, the promising results obtained in the preclinical trials have not yet been reproduced in patients. Thus, the development of novel strategies to improve stem cell efficiency became imperative. Here, an overview of the more recent cell types proposed for cardiac regeneration is presented, together with the most interesting approaches to enhance cell regenerative potential as well as cell-free approaches. Bentham Science Publishers 2020-11-10 2020-11-10 /pmc/articles/PMC8493790/ /pubmed/32096748 http://dx.doi.org/10.2174/1574888X15666200225124451 Text en © 2020 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Rurali, Erica
Vinci, Maria Cristina
Bassetti, Beatrice
Barbagallo, Veronica
Pompilio, Giulio
Gambini, Elisa
New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence
title New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence
title_full New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence
title_fullStr New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence
title_full_unstemmed New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence
title_short New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence
title_sort new strategies to enhance myocardial regeneration: expectations and challenges from preclinical evidence
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493790/
https://www.ncbi.nlm.nih.gov/pubmed/32096748
http://dx.doi.org/10.2174/1574888X15666200225124451
work_keys_str_mv AT ruralierica newstrategiestoenhancemyocardialregenerationexpectationsandchallengesfrompreclinicalevidence
AT vincimariacristina newstrategiestoenhancemyocardialregenerationexpectationsandchallengesfrompreclinicalevidence
AT bassettibeatrice newstrategiestoenhancemyocardialregenerationexpectationsandchallengesfrompreclinicalevidence
AT barbagalloveronica newstrategiestoenhancemyocardialregenerationexpectationsandchallengesfrompreclinicalevidence
AT pompiliogiulio newstrategiestoenhancemyocardialregenerationexpectationsandchallengesfrompreclinicalevidence
AT gambinielisa newstrategiestoenhancemyocardialregenerationexpectationsandchallengesfrompreclinicalevidence